Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
The AAPS Journal|December 16, 2005
On some "disadvantages" of the population approachJerry R NedelmanStatistics in Medicine|April 15, 2006
Diagnostics for confounding in PK/PD models for oxcarbazepineJerry R Nedelman, Donald B Rubin, Lewis B SheinerAntimicrobial Agents and Chemotherapy|August 14, 2019
Population Pharmacokinetics of the Antituberculosis Agent PretomanidDavid H Salinger, Vishak Subramoney, Daniel Everitt, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2021
Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant TuberculosisMarjorie Z Imperial, Jerry R Nedelman, Francesca Conradie, et al.Antimicrobial Agents and Chemotherapy|August 28, 2019
Daily Dosing for Bedaquiline in Patients with TuberculosisDavid H Salinger, Jerry R Nedelman, Carl Mendel, et al.Antimicrobial Agents and Chemotherapy|July 31, 2019
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with TuberculosisHanbin Li, David H Salinger, Daniel Everitt, et al.Antimicrobial Agents and Chemotherapy|October 20, 2020
An Exposure-Response Perspective on the Clinical Dose of PretomanidJerry R Nedelman, David H Salinger, Vishak Subramoney, et al.Pageof 1